Surface CD14 positivity in B-cell chronic lymphocytic leukaemia is related to clinical outcome

British Journal of Haematology

Volumn 107, Issue 2, 1999, Pages 347-352

  Callea, Vincenzo ^b   Morabito, Fortunato ^b   Oliva, Bianca Maria ^b   Stelitano, Caterina ^b   Levato, Domenico ^a   Dattilo, Angela ^a   Gangemi, Francesca ^b   Lorfida, Antonella ^a   Iacopino, Pasquale ^b   Nobile, Francesco ^b   Molica, Stefano ^a   Brugiatelli, Maura ^b  

^a Azienda Ospedaliera   (Italy)

^b Azienda Ospedaliera   (Italy)

Author keywords

B CLL; CD14; Overall survival; Rai stage; TTM score

Indexed keywords

CD14 ANTIGEN;

ADULT; AGED; ARTICLE; B CELL LEUKEMIA; CANCER STAGING; CANCER SURVIVAL; CHRONIC LEUKEMIA; CHRONIC LYMPHATIC LEUKEMIA; FEMALE; HUMAN; HUMAN CELL; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCORING SYSTEM;

ANTIGENS, CD14; FEMALE; FOLLOW-UP STUDIES; HUMANS; LEUKEMIA, B-CELL, CHRONIC; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; SURVIVAL RATE;

EID: 0032705712     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1999.01695.x     Document Type: Article

References (30)

1. Bennett, J.M., Catovsky, D., Daniel, M.T., Flandrin, G., Galton, D.A.G., Gralnick, H.R., Sultan, C., the French-American-British (FAB) Cooperative Group (1989) Proposal for the classification of chronic (mature) B and T lymphoid leukaemias. Journal of Clinical Pathology, 42, 567-584.
2. Binet, J.L., Auquier, A., Dighiero, G., Chastang, C., Piguet, H., Goasguen, J., Vaugier, C., Potron, G., Colona, P., Oberling, E., Thomas, M., Tchernia, G., Jaquillat, C., Boivin, P., Lesty, C., Duault, M.T. & Gremy, F. (1981) A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis. Cancer, 48, 198-206.
3. Callea, V., Morabito, F., Luise, F., Piromalli, A., Filangeri, M., Stelitano, C., Iacopino, P., Nobile, F. & Brugiatelli, M. (1996) Clinical significance of sIL2R, sCD23, sICAM1, IL6 and sCD14 serum levels in B-cell chronic lymphocytic leukemia. Haematologica, 81, 310-315.
4. Cheson, B.D., Bennett, J.M., Grever, M., Kay, N., Keating, M.J., O'Brien, S. & Rai, K.R. (1996). National Cancer Institute sponsored working group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment. Blood, 87, 4990-4997.
5. Foa, R., Massaia, M., Cardona, S., Tos, A.G., Bianchi, A., Attisano, C., Guarini, A., Francia di Celle, P. & Fierro, M.T. (1990) Production of tumor necrosis factor-alpha by B-cell chronic lymphocylic leukemia cells: a possible role of TNF in the progression of the disease. Blood, 76, 393-400.
6. Frey, E.A., Miller, D.S., Jahr, T.G., Sundan, A., Bazil, V., Espevik, K.T., Finlay, B.B. & Wright, S.D. (1992) Soluble CD14 participates in the response of cells to lipopolysaccharides. Journal of Experimental Medicine, 176, 1665-1671.
7. Goyert, S.M.E., Ferrero, W.J., Rettig, A.K., Yenamaudra, F., Obata, F. & Le Beau, M.M. (1988) The CD14 monocyte differentiation antigen maps to a region encoding growth factors and receptors. Science, 239, 497-500.
8. Grogan, T.M., Durie, B.G.M., Spier, C.M., Richter, L. & Vela, E. (1989) Myelomonocytic antigen positive multiple myeloma. Blood, 73, 763-769.
9. International Workshop on Chronic Lymphocytic Leukemia (1989) Recomendations for diagnosis, staging and response criteria. Annals of Internal Medicine, 110, 236-238.
10. Jaksic, B. & Brugiatelli, M. (1988) High dose continuous chlorambucil vs intermittent chlorambucil plus prednisone for treatment of B-CLL. Nouvelle Revue Française d'Hématologie. 30, 437-442.
11. Jaksic, B. & Vitale, B. (1981) Total tumor mass score (TTM): a new parameter in chronic lymphocytic leukaemia. British Journal of Haematology, 49, 405-413.
12. Keating, M.J., Kantarajian, H., O'Brien, S., Koller, C., Talpaz, M., Schachner, J., Chilps, C.C., Freireich, E.J. & McCredie, K.B. (1991) Fludarabine: a new agent with marked cytoreduction activity in untreated chronic lymphocytic leukemia. Journal of Clinical Oncology, 9, 44-49.
13. Molica, S. (1999) Is it time for a reassessment of prognostic features in B-cell chronic lymphocytic leukemia? Hematology and Cell Therapy, 41, 87-93.
14. Molica, S., Dattilo, A. & Alberti, A. (1991) Myelomonocytic associated antigens in B-chronic lymphocytic leukemia: analysis of clinical significance. Leukemia and Lymphoma, 5, 139-144.
15. Morabito, F., Prasthofer, E.F., Dunlap, N.E., Grossi, C.E. & Tilden, A.B. (1987) Expression of myelomonocytic antigens on chronic lymphocytic leukemia B cells correlates with their ability to produce interleukin I. BIood, 70, 1750-1757.
16. Morrison, D.C. & Ryan, J.L. (1987) Endotoxin and disease mechanism. Annual Review of Medicine, 38, 417-422.
17. Nakase, K., Kita, K., Shiku, H., Tanaka, I., Nasu, K., Dohy, H., Kyo, T., Tsutani, H. & Kamada, N. (1996) Myeloid antigen, CD13, CD14 and/or CD33 expression is restricted to certain lymphoid neoplasms. American Journal of Clinical Pathology, 105, 761-768.
18. Pinto, A., Colletta, G., Del Vecchio, L., Rosati, R., Attadia, V., Cimino, R. & Colombatti, A. (1987) c-fos expression in human hemopoietic malignancies is restricted to acute leukemias with monocytic phenotype and to subset of B cell leukemias. Blood, 70, 1450-1457.
19. Pinto, A., Zagonel, V., Carbone, A., Serraino, D., Marotta, G., Volpe, R., Colombatti, A. & Del Vecchio, L. (1992) CD13 expression in B-cell chronic lymphocytic leukemia is associated with the pattern of bone marrow infiltration. Leukemia and Lymphoma, 6, 209-218.
20. Polliack, A., Rabinowitz, R., Leizerowitz, R., Keren-Zur, Y. & Schlesinger, M. (1993) Myelomonocytic antigens are rarely expressed on B-lymphocytic leukemia cells. Leukemia and Lymphoma, 9, 125-131.
21. Rai, K.R., Sawitsky, A., Cronkite, E.P., Chamana, A.D., Levy, R.N. & Pasternak, B.S. (1975) Clinical staging of chronic lymphocytic leukemia. Blood, 46, 219-234.
22. Rozman, C., Montserrat, E., Rodriguez-Fernandez, J.M., Ayats, R., Vallespì, T., Parody, R., Rios, A., Prados, D., Gomis, F., Alcala, A., Gutierrez, M., Maldonado, J., Gonzales, C., Giralt, M., Hernandez-Nieto, L., Cabrera, A. & Fernandez-Ranada, J.M. (1984) Bone marrow histologic pattern, the best single prognostic parameter in chronic lymphocytic leukemia: a multivariate survival analysis of 329 cases. Blood, 64, 642-648.
23. Sobol, R.E., Mick, R., Royston, I., Davey, F.R., Ellison, R.R., Newman, R., Cuttner, J., Griffin, J.D., Collins, H., Nelson, D.A. & Bloomfield, C.D. (1987) Clinical importance of myeloid antigen expression in adult lymphoblastic leukemia. New England Journal of Medicine, 316, 1111-1117.
24. Tassies, D., Montserrat, E., Reverter, J.C., Villamor, N., Rovira, M. & Rozman, C. (1995) Myelomonocytic antigens in B-cell chronic lymphocytic leukemia. Leukemia Research, 19, 841-848.
25. Travade, P., for the French Cooperative Group on CLL (1990) The experience of the French Cooperative Group in the treatment of CLL. Nouvelle Revue Française d'Hématologie, 32, 313-317.
26. Uggle, C., Aguilar-Santelises, M., Rosen, A., Mellstedt, H. & Jondel, M (1987) Spontaneous production of interleukin I activity by chronic lymphocytic leukemia cells. Blood, 70, 1851-1857.
27. Wiersma, S.R., Ortega, J., Sobel, E. & Weinberg, K.I. (1991) Clinical importance of myeloid antigen expression in acute lymphoblastic leukemia of childhood. New England Journal of Medicine, 324, 800-825.
28. Woessner, S., Florensa, L., Besses, C., Vila, R.M., Galles, C., Palou, L. & Sabrafen J.S. (1442) Immunocytochemical investigation of normal and chronic lymphocytic leukemia lymphocytes reveals frequent reactivity with some myelomonocytic associated antibodies. Leukemia Research, 16, 505-510.
29. Wormsley, S.B., Saiget, S.L., Gadol, N. & Rai K.R. (1990) Will the real CD14 please stand up? Blood, 76, 393a (abstract 1563).
30. Wright, S.D., Ramos, R.A., Tobias, P.S., Ulevitch, R.J. & Mathison, J.C. (1990) CD14, a receptor for complexes of lipopolysaccharides (LPS) and LPS binding protein. Science, 249, 1431-1433.